Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nehad M Ayoub

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
The Breast Journal|February 9, 2020
Idiopathic granulomatous mastitis in the male population: A clinical analysis of 13 reported casesRami J Yaghan, Nehad M Ayoub, Hamdi M Shenawi, et al.
Journal of Nanoscience and Nanotechnology|April 17, 2014
Entrapment into nanoemulsions potentiates the anticancer activity of tocotrienols against the highly malignant (+SA) mouse mammary epithelial cellsAlaadin Alayoubi, Nehad M Ayoub, Abhita Malaviya, et al.
Frontiers in Pharmacology|March 14, 2022
Targeting Angiogenesis in Breast Cancer: Current Evidence and Future Perspectives of Novel Anti-Angiogenic ApproachesNehad M Ayoub, Sara K Jaradat, Kamal M Al-Shami, et al.
Investigational New Drugs|August 25, 2020
Crizotinib induced antitumor activity and synergized with chemotherapy and hormonal drugs in breast cancer cells via downregulating MET and estrogen receptor levelsNehad M Ayoub, Dalia R Ibrahim, Amer E Alkhalifa, et al.
Technology in Cancer Research & Treatment|February 23, 2024
Targeting Receptor Tyrosine Kinases as a Novel Strategy for the Treatment of Triple-Negative Breast CancerSara K Jaradat, Nehad M Ayoub, Ahmed H Al Sharie, et al.
Current Cancer Drug Targets|October 11, 2024
The Clinicopathological and Prognostic Significance of the Expression of PD-L1 and MET Genes in Breast Cancer: Potential Therapeutic TargetsMuhsen Al-Diabat, Nehad M Ayoub, Laith Al-Eitan, et al.
Oncotargets and Therapy|October 19, 2017
Crizotinib, a MET inhibitor, inhibits growth, migration, and invasion of breast cancer cells in vitro and synergizes with chemotherapeutic agentsNehad M Ayoub, Kamal M Al-Shami, Mohammad A Alqudah, et al.
Breast Cancer (Dove Medical Press)|November 22, 2021
Programmed Death-Ligand 1 Expression in Breast Cancer Patients: Clinicopathological Associations from a Single-Institution StudyNehad M Ayoub, Mona Fares, Raya Marji, et al.
Fitoterapia|December 26, 2012
Sesamin synergistically potentiates the anticancer effects of γ-tocotrienol in mammary cancer cell linesMohamed R Akl, Nehad M Ayoub, Bilal S Abuasal, et al.
Current Drug Delivery|June 24, 2011
Dark chocolate and blood pressure: a novel study from JordanSaafan A Al-Safi, Nehad M Ayoub, Imad Al-Doghim, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
The Breast Journal|February 9, 2020
Idiopathic granulomatous mastitis in the male population: A clinical analysis of 13 reported casesRami J Yaghan, Nehad M Ayoub, Hamdi M Shenawi, et al.
Journal of Nanoscience and Nanotechnology|April 17, 2014
Entrapment into nanoemulsions potentiates the anticancer activity of tocotrienols against the highly malignant (+SA) mouse mammary epithelial cellsAlaadin Alayoubi, Nehad M Ayoub, Abhita Malaviya, et al.
Frontiers in Pharmacology|March 14, 2022
Targeting Angiogenesis in Breast Cancer: Current Evidence and Future Perspectives of Novel Anti-Angiogenic ApproachesNehad M Ayoub, Sara K Jaradat, Kamal M Al-Shami, et al.
Investigational New Drugs|August 25, 2020
Crizotinib induced antitumor activity and synergized with chemotherapy and hormonal drugs in breast cancer cells via downregulating MET and estrogen receptor levelsNehad M Ayoub, Dalia R Ibrahim, Amer E Alkhalifa, et al.
Technology in Cancer Research & Treatment|February 23, 2024
Targeting Receptor Tyrosine Kinases as a Novel Strategy for the Treatment of Triple-Negative Breast CancerSara K Jaradat, Nehad M Ayoub, Ahmed H Al Sharie, et al.
Current Cancer Drug Targets|October 11, 2024
The Clinicopathological and Prognostic Significance of the Expression of PD-L1 and MET Genes in Breast Cancer: Potential Therapeutic TargetsMuhsen Al-Diabat, Nehad M Ayoub, Laith Al-Eitan, et al.
Oncotargets and Therapy|October 19, 2017
Crizotinib, a MET inhibitor, inhibits growth, migration, and invasion of breast cancer cells in vitro and synergizes with chemotherapeutic agentsNehad M Ayoub, Kamal M Al-Shami, Mohammad A Alqudah, et al.
Breast Cancer (Dove Medical Press)|November 22, 2021
Programmed Death-Ligand 1 Expression in Breast Cancer Patients: Clinicopathological Associations from a Single-Institution StudyNehad M Ayoub, Mona Fares, Raya Marji, et al.
Fitoterapia|December 26, 2012
Sesamin synergistically potentiates the anticancer effects of γ-tocotrienol in mammary cancer cell linesMohamed R Akl, Nehad M Ayoub, Bilal S Abuasal, et al.
Current Drug Delivery|June 24, 2011
Dark chocolate and blood pressure: a novel study from JordanSaafan A Al-Safi, Nehad M Ayoub, Imad Al-Doghim, et al.
Pageof 7